Thursday, April 28, 2022

Protease Inhibitors and Integrase Inhibitors Show Early Promise in Protecting Against Covid-19

›
By:  Ranier Simons , ADAP Blog Guest Contributor The scientific and medical world is still actively researching and learning about Covid-19....
Thursday, April 21, 2022

Medical Debt is a Severe Financial Burden in the United States

›
By:  Ranier Simons , ADAP Blog Guest Contributor Medical debt is a major financial crisis in the United States. It is a major barrier to fin...
Thursday, April 14, 2022

Industry’s Changes to 340B Drug Discount Program

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association, and Jen Laws, President & CEO, Community Access National Network (CANN) The Comm...
Thursday, April 7, 2022

A Rare Personal Appeal to My POZ Brothers & Sisters; Please Protect Yourself

›
By: Brandon M. Macsata , CEO, ADAP Advocacy Association For nearly 15 years, I've had the distinct honor of serving as the CEO of the AD...
Thursday, March 31, 2022

Profiting From Misery Because They Can

›
By:  Marcus J. Hopkins , Founder & Executive Director, Appalachian Learning Initiative Since the passage of the Affordable Care Act (ACA...
Thursday, March 24, 2022

Gilead Sciences Discovers $250 Million of Counterfeit Biktarvy and Descovy

›
By:  Ranier Simons , ADAP Blog Guest Contributor The selling of counterfeit goods is a lucrative market. Expensive, popular, and high-demand...
Thursday, March 17, 2022

Better Together: A Collaborative Model to Address Health Equity

›
By: Alan Richardson , Executive Vice President of Strategic Patient Solutions, Patient Advocate Foundation Since our inception 25 years ago,...